Publications by authors named "Michael Banov"

Claim this Profile
E
Efficacy of Intravenous Racemic Ketamine on Global Severity and Individual Symptoms of Depression: An Exploratory Retrospective Analysis.
Rachel E Landrum, Amanda M Raines, Philip D Harvey, Michael D Banov, Kevin G Saulnier

J Clin Psychopharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trial.
Charles R Conway, Scott T Aaronson, Harold A Sackeim, Mark S George, John Zajecka, Michael Banov

Brain Stimul· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching to Intranasal Esketamine Maintains the Antidepressant Response to Intravenous Racemic Ketamine Administration: A Case Series of 10 Patients.
Michael D Banov, Rachel E Landrum, Michelle B Moore, Steven T Szabo

J Clin Psychopharmacol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: a review of the literature.
Michael D Banov, Jonathan R Young, Tyler Dunn, Steven T Szabo

CNS Spectr· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects.
Scott T Aaronson, Linda L Carpenter, Charles R Conway, Frederick W Reimherr, Sarah H Lisanby, Michael D Banov

Brain Stimul· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study.
Brian Bortnick, Nizar El-Khalili, Michael Banov, David Adson, Catherine Datto

J Affect Disord· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.
Mauricio Tohen, Eduard Vieta, Guy M Goodwin, Bin Sun, Jay D Amsterdam, Michael Banov

J Clin Psychiatry· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of PRX-00023, a novel, selective serotonin 1A receptor agonist on measures of anxiety and depression in generalized anxiety disorder: results of a double-blind, placebo-controlled trial.
Karl Rickels, Sanjay Mathew, Michael D Banov, Daniel L Zimbroff, Scott Oshana

J Clin Psychopharmacol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.
Mauricio Tohen, Joseph R Calabrese, Gary S Sachs, Michael D Banov, Holland C Detke

Am J Psychiatry· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis